CLOs on the Move


 
BioTime is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. BioTime`s pipeline is based on two platform technologies which encompass cell replacement and cell/drug delivery. BioTime`s lead cell replacement product candidate is OpRegen®, a retinal pigment epithelium transplant therapy in Phase 2 development for the treatment of dry age-related macular degeneration, the leading cause of blindness in the developed world. BioTime common stock is traded on the NYSE American and TASE under the symbol BTX.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.biotimeinc.com
  • 1010 Atlantic Avenue Suite 102
    Alameda, CA USA 94501
  • Phone: 510.521.3390

Executives

Name Title Contact Details
Chase Leavitt
General Counsel and Corporate Secretary Profile

Similar Companies

Jasper Clinical Research and Development

Jasper Clinical Research & Development, Inc. is a Kalamazoo, MI-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Pharma Connections Worldwide

Pharma Connections Worldwide is a Cambridge, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Biotech Medical

Biotech Medical is a Canton, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Kinnos

Our patented and award-winning Highlight® technology makes it easy to use disinfectants correctly.

Risdall Marketing Group

Risdall Marketing Group is a Saint Paul, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.